Open Access<p>Serum Exosomal miR-1290 is a Potential Biomarker for Lung Adenocarcinoma</p>
Author(s) -
Yifan Wu,
Jia Wei,
Wei Zhang,
Mengxiao Xie,
Xueying Wang,
Jian Xu
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s263934
Subject(s) - medicine , lung cancer , biomarker , adenocarcinoma , microvesicles , microrna , exosome , oncology , downregulation and upregulation , cancer , metastasis , stage (stratigraphy) , tumor progression , cancer research , biology , gene , biochemistry , paleontology
Lung cancer is a leading cause of cancer-related death, with lung adenocarcinoma (LUAD) representing the most common subtype. Recently, exosome-based biomarkers have provided new diagnostic approaches for malignancies. We aimed to identify specific exosomal microRNAs (miRNAs) as noninvasive biomarkers for LUAD.